Compare Stocks

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABCN VIVO Cannabis	C$1.32 +5.6%	C$1.32	C$0.80 ▼ C$4.06	C$256.62M	N/A	1.51 million shs	310,601 shs
ATTBF Abattis Bioceuticals		$0.00	$0.00 ▼ $0.00	N/A	N/A	11,650 shs	N/A
LTY Liberty Biopharma	C$2.00 +∞	C$2.00	C$0.06 ▼ C$2.74	C$21.54M	N/A	23,286 shs	700 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABCN VIVO Cannabis	0.00%	0.00%	0.00%	0.00%	0.00%
ATTBF Abattis Bioceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
LTY Liberty Biopharma	0.00%	0.00%	0.00%	0.00%	0.00%

Now Open: Crypto emergency update (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LTY Liberty Biopharma	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A
LTY Liberty Biopharma	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A	N/A
LTY Liberty Biopharma	N/A	N/A	C$0.00 per share	2,000.00	C$0.79 per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABCN VIVO Cannabis	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	-$0.16	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LTY Liberty Biopharma	N/A	-C$0.16	N/A	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A
LTY Liberty Biopharma	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABCN VIVO Cannabis	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A
LTY Liberty Biopharma	8.19	0.12	0.12

Ownership

Institutional Ownership

Company	Institutional Ownership
ABCN VIVO Cannabis	N/A
ATTBF Abattis Bioceuticals	32.45%
LTY Liberty Biopharma	N/A

Insider Ownership

Company	Insider Ownership
ABCN VIVO Cannabis	N/A
ATTBF Abattis Bioceuticals	N/A
LTY Liberty Biopharma	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ABCN VIVO Cannabis	N/A	194.41 million	N/A	Not Optionable
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	Not Optionable
LTY Liberty Biopharma	N/A	10.77 million	N/A	Not Optionable

LTY, ATTBF, ABCN, ABZA, and AHZ Headlines

Source	Headline
	Liberty Biopharma (CVE:LTY) Stock Price Passes Above 50-Day Moving Average of $2.00 americanbankingnews.com - April 16 at 3:54 AM
	Moms for Liberty wants funds cut to Alabama libraries that let kids check out ‘pornographic material’ al.com - January 11 at 2:44 PM
	Right wing Moms for Liberty group making moves in staunchly blue Manhattan nydailynews.com - January 9 at 1:56 PM
	Why Liberty Latin America Ltd. (LILA) Has an Undervalued Rating? msn.com - January 3 at 7:54 AM
	ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees markets.businessinsider.com - January 3 at 7:54 AM
	Liberty Hospital is still recovering systems days after cyber attack bizjournals.com - December 29 at 4:01 PM
	Microbot’s Liberty Robotic System Meets Objectives in Pivotal Preclinical Study evtoday.com - December 29 at 12:27 AM
	Redhill Biopharma Ltd ADR morningstar.com - December 27 at 11:29 PM
	Moms for Liberty faces growing challenges amid Florida sex scandal news.yahoo.com - December 23 at 7:01 PM
	One Liberty (OLP) Completes Asset Sale Worth $63M in 2023 msn.com - December 22 at 1:50 PM
	Delayed Liberty Hospital surgery could cost patient thousands if IT issues continue msn.com - December 21 at 12:48 AM
	Liberty Travel Partners with Affirm to Bring Travelers a More Flexible Way to Book Trips tmcnet.com - December 18 at 9:53 AM
	Liberty 99, St. Andrews 26 sfgate.com - December 16 at 3:24 PM
	Here's Why Liberty Park Capital's Short Position in Powell Industries (POWL) Detracted msn.com - December 16 at 10:23 AM
	Liberty Home Guard review usatoday.com - December 13 at 6:31 PM
	Liberty Shoes Ltd (LIBERTSHOE) Share Price businesstoday.in - December 12 at 8:31 PM
	Liberty Media to merge unit with SiriusXM to create new public company reuters.com - December 12 at 10:30 AM
	Moms for Liberty's vision for America's future is narrow and dark. Why not help kids? news.yahoo.com - December 7 at 7:41 AM
	LDDFF Liberty Defense Holdings, Ltd. seekingalpha.com - November 29 at 1:13 PM
	RedHill Biopharma Shares Double on FDA's 5-Year Market Exclusivity Grant marketwatch.com - November 27 at 6:06 PM
	Immunotech Biopharm Ltd Ordinary Shares 06978 morningstar.com - November 22 at 7:21 PM
	Liberty Shoes Ltd. Share Price financialexpress.com - November 18 at 9:11 AM
	The Liberty Conservative: Major Army Battalion Surrenders to Ethnic Resistance Group in Northern Myanmar thelibertyconservative.com - November 15 at 7:16 PM
	SMEs Turn to Flexible Business Loans to Keep Up with Technological Change kansascity.com - November 10 at 7:53 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

VIVO Cannabis

CVE:ABCN

ABcann Global Corporation manufactures and distributes medical cannabis. The company is headquartered in Napanee, Canada.

Abattis Bioceuticals

OTCMKTS:ATTBF

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

Liberty Biopharma

CVE:LTY

Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease. The company was formerly known as Avagenesis Corp. and changed its name to Liberty Biopharma Inc. in January 2017. Liberty Biopharma Inc. is based in Richmond, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial